Key points are not available for this paper at this time.
A 58-year-old male was admitted to the tuberculosis (TB) department with fever, moderate cough, night sweats, weight loss of 10 kg, and loss of appetite.The patient had been receiving intravesical Bacillus Calmette-Guérin (BCG) instillations, for nine months, as immunotherapy for bladder cancer.The high-grade superficial (pT1) urothelial cancer was
Skowroński et al. (Wed,) studied this question.